Joseph Lockinger

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Cooley advised Biote, a medical practice-building business within the hormone optimization space, on its definitive business combination agreement with special purpose acquisition company (SPAC) Haymaker Acquisition Corp III. Lawyers Michal Berkner and Jarrett Burks led the Cooley team advising Biote.

Cooley advised DailyPay, an on-demand pay solution for enterprises, on its $175 million Series D financing round, as well as its $325 million of credit capital from various sources. Sacha Ross and Ariel Rom led the Cooley team advising DailyPay on the investments, which propelled the fintech company to unicorn status.

Cooley advised White Ops, a leader in bot mitigation, bot prevention and ad fraud prevention, on its sale to Goldman Sachs Merchant Banking Division, ClearSky Security, and Nightdragon. Lawyers Izzy Lubarsky, Eric Dixon, Alex Fagella, Tanisha James, Stephanie Gentile, Joshua Friedman and Joseph Lockinger led the Cooley team. 

Cooley advised SevenRooms, a data-driven guest experience platform for the hospitality industry, on its $50 million Series B funding round led by Providence Strategic Growth.

The new capital will support SevenRooms’ continued global expansion and enable the company to further enhance its platform focused on helping operators build profitable, direct relationships with their guests. In conjunction with the investment, PSG Managing Director Adam Marcus will join SevenRooms’ board of directors.

The Cooley team advising SevenRooms on the funding round included Stephane Levy, Tamim Bazzi, Adam Alperowicz, Jayne Munger, Adam Ruttenberg, Eric Tobias, Stephanie Gentile, Gerard O’Shea and Joseph Lockinger.